In the current issue Mertzanidou et al. (2012) report a detailed chromosome study of cleavage-stage embryos using a version of the array comparative genomic hybridization (aCGH) technique. The aCGH technique is widely used in the genetics field and this study provides an opportunity to offer some guidance to the journal reader on its scope and limitations when applied to early human embryos, and the interpretation of the complex results sometimes obtained.
Chromosome analysis and the interpretation of the results can be challenging and the terminology confusing. There are now a number of fundamentally different techniques in routine use, including karyotyping, fluorescence in situ hybridization (FISH), comparative genomic hybridization, microarray (BAC and oligonucleotide aCGH, SNP microarray) and multiple ligation-dependent probe amplification. Specific systems of international nomenclature have been developed to cope with them and to improve and maintain international collaboration (ISCN, 2009) .
Classical karyotyping is the visual examination of stained and banded chromosome preparations using a light microscope and underpins our basic understanding of chromosomes. A human karyogram (a systematized arrangement of the paired chromosome images) is arranged such that the autosomes (chromosomes not controlling sex) are numbered from 1 to 22 in order of decreasing length, and displayed separately from the sex chromosomes (X and Y) (Genetics Home Reference image: http://ghr.nlm.nih.gov/handbook/illustrations/ normalkaryotype, accessed 23 August 2012). Karyotyping can count and identify individual chromosomes (using banding techniques) and detect structural rearrangements within and between chromosomes, including those with no loss or gain of material (e.g. balanced translocations and inversions) (Genetics Home Reference image: http://ghr .nlm.nih.gov/handbook/illustrations/balancedtranslocation, accessed 23 August 2012). By systematically comparing each pair of chromosomes, karyotyping can also detect a partial absent region in one chromosome (deletion) or an extra copy of a region (duplication). Clinically significant single anomalies typically are not inherited (they arise de novo) but a terminal deletion of one chromosome and a terminal duplication of another chromosome could indicate an unbalanced translocation following meiotic segregation of a parental balanced reciprocal translocation.
One copy of every chromosome has a total of just over 3 billion base pairs of DNA (3196 Mbp, Genome Reference Consortium: http://www.ncbi.nlm.nih.gov/projects/genome/assembly/grc/human/ data/index.shtml, accessed 23 August 2012) and, in skilled hands, karyotyping can usually detect chromosome anomalies .5 -10 million base pairs (5 -10 Mbp). When applied to the investigation of a child or adult with congenital abnormalities and/or mental disability, chromosome imbalance of this magnitude of a region containing genes, and present in every cell in the body, is expected to be clinically significant and associated with the referral reason. Karyotyping usually requires culture and synchronization of cell division using toxic reagents in order to obtain and analyse chromosome preparations effectively. Therefore, it is therefore generally not suitable for human embryos that are required for patient use.
Bacterial artificial chromosome (BAC) microarrays for chromosome analysis typically do not include highly repetitive sequences such as are found in the short arms of the acrocentric chromosomes (chromosomes 13, 14, 15, 21 and 22) , the chromosome centromere and telomere regions, heterochromatic variable regions (e.g. band q12 on chromosome 1, band q12 on chromosome 9, band q11.2 on chromosome 16), or entirely include the rest of the genome. In practice, a '24-chromosome' BAC array includes only a large number of segments of every chromosome (1-22,X,Y). The array used by Mertzanidou et al. in their study covers 16% of the total genomic sequence.
Microarray-based chromosome analysis compares a sample of DNA with a reference DNA sample. This technique can only detect copy number changes (gain or loss) of the DNA segments included on the array, and cannot detect balanced chromosome rearrangements (no loss or gain of material) or identify specifically where any additional genetic material detected is located. Only visual examination of chromosomes can definitively establish the number of chromosomes, detect balanced rearrangements and locate the actual position of extra material. However, test DNA can be extracted from a cell sample biopsied from an embryo with minimal interference to the embryo.
Mertzanidou et al. detected a large number of regions of chromosomal imbalance in the cells from the embryos they tested (Mertzanidou et al.: Table I ). It is instructive in the context of this article to analyse some of these in more detail. However, first we should define some terms and also consider the cells where no imbalance was detected.
Euploidy is defined to be any multiple of the haploid chromosome number (n), e.g. 23,X or 23,Y (one copy of every autosome and either the X or Y chromosome, haploid, 1n), 46,XX or 46,XY (two copies of every autosome and an XX female or XY male sex chromosome complement, diploid, 2n), 69,XXX or 69,XXY or 69,XYY (three copies of every autosome and three sex chromosomes, triploid, 3n) and 92,XXXX or 92,XXYY (four copies of every chromosome and four sex chromosomes, tetraploid, 4n), and therefore also includes normal (diploid) and abnormal (haploid and polyploid) chromosome complements. Aneuploidy is defined to be any numerical (i.e. whole chromosome) deviation from the euploid chromosome number. In the context of chromosomal analysis of a child or adult it can be assumed with near certainty that a euploid aCGH result will indicate a diploid chromosome complement because none of the other euploid complements are viable. However, in the early human embryo we can expect to see every variety of euploid chromosome complements and, because aCGH analyses a ratio rather than counting chromosomes as such, a 'normal' test result does not guarantee a diploid chromosome complement.
A diploid 46,XY karyotype result indicates that there are two copies of every autosome and an XY (male) sex chromosome complement, and that no visible rearrangement of the chromosomes was detected. The same individual tested using a BAC microarray would be reported using different nomenclature because the technique cannot detect balanced rearrangement of the chromosomes, viz. arr(1-22)x2,(XY)x1, which assumes diploidy and indicates that a normal copy number was found for all the regions of the autosomes and the sex chromosomes tested. It is worth noting that the FISH technique is also visual in character and the number of regions tested can be counted and therefore different euploidy states can be differentiated provided that at least two chromosomes are tested.
The general principle for reporting abnormal microarray results is to list only the aberrations. Considering cell 3.1 in Mertzanidou et al.'s Table I , where one unbalanced region (loss) was detected. This result indicates a loss of the long arm of chromosome 5 at bands q12.1 through q35.3, which is 119.0 Mbp in size (180 626 608 -61 659 616 ¼ 118 966 992 base pairs). The next nucleotide included on the array before the deleted segment which does not show a loss is 761 916 nucleotides away (61 659 616 -60 897 700), i.e. there is a gap in the coverage, and finally the loss also includes the most distal nucleotide on the array. For the appropriate build of the human genome sequence for the data, chromosome 5 has 180 857 866 nucleotide pairs so the array does not include the last 231 258 nucleotides (180 857 866-180 626 608) and therefore we cannot be certain whether it is a terminal or an interstitial deletion (Fig. 1) . In the context of a male child (although in reality this degree of imbalance in every cell in the body would not be viable) the microarray result would be reported as: arr 5q12.1q35.3(60 897 700×2 61 659 616-180 626 608×1), and the karyotype result as: 46,XY,del(5) (q12.1). The karyotype result assumes (rightly or wrongly) that it is a terminal deletion because any material distal to the deletion is too small to resolve by microscopy (in situ hybridization using a probe specific for the sub-telomere region might be used to resolve this). From a clinical perspective this is usually academic, unless it is the unbalanced product of a balanced parental translocation, with a risk of recurrence in future offspring.
The results in Mertzanidou et al.'s Table I which are most likely to represent aneuploidy (whole-chromosome gain or loss) are those where the gain or loss includes all segments on the array for a chromosome. Considering cell 3.3 in Table I , where one unbalanced region (gain) was detected. This result indicates a gain of the long arm of chromosome 22 at bands q11.1 through q13.33, which is 33.8 Mbp in size (49 464 725 -15 615 802 ¼ 33 848 923 bp). The table shows that no regions of euploid copy number were detected and that the array does not cover the short arm or centromere region of chromosome 22 ( 15.6 Mbp). It is likely that this result indicates an extra copy of an entire chromosome 22. The array result therefore shows a significant gain of chromosome 22 material and it is likely to represent a diploid cell with primary trisomy 22 (47 chromosomes, +22) but it does not exclude the possibility that it could represent the long arm of chromosome 22 translocated onto another chromosome (associated with 46 chromosomes in a diploid cell but with partial trisomy for the long arm of chromosome 22). Only visual examination of the chromosomes themselves could conclusively differentiate between these possibilities (Fig. 2) . It is worth mentioning here that the long arm of chromosome 22 has 34 million nucleotides and only around 6 million are included in the array (i.e. there are lots of gaps); however, because the segments covered by the array are dispersed down the entire chromosome arm we can assume that gap regions are also included in the region of gain.
Of related interest is cell 13.3. The array detected a loss of Y chromosome material (probably the whole chromosome) and a partial gain of the long arm of chromosome 22 at bands q11.1 through q12.3, which is 19.3 Mbp in size. Again the table shows that the array does not cover the short arm, and this time indicates that the next distal nucleotide on the array which does not show a gain is 524 710 nucleotides away. This result could indicate a contiguous duplication of the regions 22q11.1-q12.3, but the duplicated region might be on another chromosome (both possibilities would be associated with 46 chromosomes in a diploid cell and partial trisomy for 22q11.1-q12.3). However, because the array does not include the short arm or centromere sequences, the possibility of a supernumerary ring chromosome 22 (47 chromosomes) cannot be excluded (Genetics Home Reference image: http://ghr.nlm.nih.gov/handbook/ illustrations/ringchromosome, accessed 23 August 2012). Again, visual examination of the chromosomes would be needed and in situ hybridization using a probe specific for the region hybridized to a chromosome spread would be required to confirm any of these possibilities (Fig. 3) .
The authors have identified two cells with a different putative ring chromosome 1 (cells 4.6 and 8.4, which are from embryos from different patients). The table shows that there is a region of gain in the short arm and long arm in both cases and euploid regions beyond these. The array does not include the centromere region or the variable heterochromatic band 1q12, but both are contained within the gain regions. As the centromere region and proximal short and long arm regions are involved, it is unlikely to represent tandem duplication or involve another chromosome, and the most likely interpretation is that these results indicate the presence of different supernumerary ring chromosomes 1 (Fig. 4) . Again, visualization of the chromosomes would be conclusive (and would require FISH to demonstrate that the supernumerary chromosome was definitely a ring and chromosome 1 in origin).
In the context of early human embryos, chromosome analysis using aCGH may sometimes be expected to produce very complex results because viable and non-viable imbalance (not found in a child or adult) can be present. Complex results are not particularly amenable to the ISCN format for copy number detection and a table, as presented by Mertzanidou et al., is an effective method to report accurately and completely complex embryo results and to ensure the best interpretation.
